Variable Bioavailability of Papaverine

Pharmacology & Toxicology

Volumn 62, Issue 5, 1988, Pages 308-310

  Berg, Göran ^a   Jönsson, Kjell‐Åke ^a   Hammar, Mats ^a   Norlander, Björn ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PAPAVERINE;

ADULT; BIOAVAILABILITY; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; IRRITABLE COLON; MALE; METHODOLOGY; NORMAL HUMAN; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADULT; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLONIC DISEASES; HUMAN; INJECTIONS, INTRAVENOUS; MALE; PAPAVERINE;

EID: 0023937173     PISSN: 09019928     EISSN: 16000773     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1988.tb01893.x     Document Type: Article

References (11)

1. Papaverine hydro‐chloride ‐ the evaluation of two new dosage forms
2. The fate of papaverine in man and other mammals
3. In virro study of phosphodie‐sterase‐inhibiting drugs: A complement to beta‐sympathomimetic drug therapy in premature labor
4. Pharmacokinetics of papaverine hydrochloride and the biophar‐maceutics of its oral dosage forms
5. High‐performance liquid chromatographic determination of papaverine in whole blood
6. Determination of Noscapi‐ne in plasma by liquid chromatography
7. Inhibition of cyclic‐3′,5′‐nucleotide‐phosphodiesterase as a possible mode of action of papaverine and similarly acting drugs
8. Comparison of various columns for the high speed HPLC analysis of drug for forensic interest
9. The influence of dosage form on papaverin bioavailability
10. Pharmacokinetics of papaverine in man
11. Management of chronic brain syndrome secondary to cerebral arteriosclerosis, with special reference to papaverine hydrochloride